1BeyersdorffD? Taupitz M, Winkelmann B, et al. Patients with ahistory of elevaled prostate-specific antigen levels and negativetransrectal US-guadrant or sextant biopsy esuhs: value of MR im-aging[J] . Radiology,2002 ,224(3) :701.
8HovsseinzadehK,Schwarz SD. Endorectal diffusion-weighted im-aging in prostate cancer to differentiate malignant and benignperipheral zone tissue[J] . J Magn Reson Imaging,2004,20 : 654.
9KononenJ, Bubendorf L,Kallioniemi A, et al. Tissue microar-rays for high-throughput molecular profiling of tumor specimens[J] . Nat Med, 1998,4(7) :844.
10KajiY,Kurhanewicz J,Hricak H,et al. Localizing prostate canc-er in the presence of postbiopsy changes on MR images: role ofproton MR spectroscopic imaging[J] . Raiology, 1998,206, ( 3):785.
6Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24-0.7 cm3) spatial resolution. Radiology, 1996, 198: 795-805.
7Kurhanewicz J, Vigneron DB, Males RG, et al. The prostate: MR imaging and spectroscopy. Radiol Clin North Am, 2000, 38: 115-138.
8van der Kwast TH, Lopes C, Santonja C, et al. Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol,2003, 56: 336-340.
9Ochiai A, Babaian RJ. Update on prostate biopsy technique. Curr Opin Urol, 2004, 14: 157-162.
10Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma. Abdom Imaging, 2001, 26: 111-122.
